Navigation Links
DNA Therapeutics Reports a Novel Mechanism of Action and a,Biomarker of its Lead Molecule Dbait That Open an Innovative,Pathway-Targeting in Molecular Cancer Therapy

EVRY, France, April 12, 2007 /PRNewswire/ -- DNA Therapeutics S.A. an emerging pharmaceutical company specialized in innovative cancer therapy announces today the elucidation of a new mechanism of action and the identification of a biomarker of its first-in-class antitumoral lead molecule Dbait. It will be presented at the forecoming American Association for Cancer Research annual meeting 2007. Its abstract is now available online. The presentation itself will be available from April 16th onwards at http://www.dna-therapeutics.com/doc/File/pdf/AACR2K7.pdf

Background: Most of the cancer therapies induce directly or indirectly DNA double strand breaks (DSBs), but unfortunately cells possess DNA repair complexes specialized in repairing these lethal lesions, which are responsible of lessened efficacy, or refractoriness of classical therapies.

A new family of anticancer drugs, named short inhibiting DNA (siDNA), has been designed by DNA Therapeutics' scientific founder team to inhibit these repair activities. The first lead, named Dbait, mimics DSBs, diverts DSB repair system from their primary objective, and facilitates cancer cells killing by traditional therapies.

The proof of concept work was presented last November at the 18th EORTC-NCI-AACR Symposium "Molecular Targets and Cancer Therapeutics" (Prague): the median survival of nude mice grafted with human tumor cell lines treated by intra-tumoral injection of Dbait, in association with radiotherapy, is significantly increased in a dose-dependent manner. MRI and cytology analysis of tumors shows that Dbait strongly enhances irradiation-induced necrosis and apoptosis.

New finding: The present study aims at deciphering the underlying mechanism of action of Dbait at molecular and cellular levels, and in particular its impact on DSB repair foci organi
'"/>




Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:11/21/2014)... and MELVILLE, N.Y. , ... CAH ), one of the world,s largest health ... HSIC ), the world,s largest provider of health ... and medical practitioners, today announced that the companies have ... of the most comprehensive service and product offerings to ...
(Date:11/21/2014)... LAVAL, QC , Nov. 20, 2014 /CNW Telbec/ ... pleased to announce the following appointments: ... leadership team in the newly created role of Chief ... a BioPhotonic system using topical photoconverter gel for the ... as surgical and traumatic wounds, recently approved in ...
(Date:11/21/2014)... HILLS, Calif. , Nov. 20, 2014 Oxis ... Ken Eaton , the election of Anthony J. Cataldo ... as President. Effective November 19, 2014, Ken ... member of the Board of Directors of Oxis International, Inc. ... Cataldo has been named Chief Executive Officer of Oxis ...
Breaking Medicine Technology:Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3
... of endoscopic ablation therapy using the HALO System ... controlled trialSUNNYVALE, Calif., May 27 Results from ... New England Journal of Medicine reveal that ... Inc.) is highly effective for complete eradication of ...
... the,presentation of data with PROSTVAC(TM) - a promising, late-stage vaccine,candidate ... hosting a Q&A session at the ASCO Annual Meeting. , ... 09 AM EDT to 10 AM EDT. , ... Florida,32819 , At the Q&A session, ...
Cached Medicine Technology:Study in the New England Journal of Medicine Shows Non-Surgical Treatment for Pre-Cancerous Condition of Esophagus is Effective and Reduces Risk for Cancer Development 2Study in the New England Journal of Medicine Shows Non-Surgical Treatment for Pre-Cancerous Condition of Esophagus is Effective and Reduces Risk for Cancer Development 3
(Date:11/22/2014)... 2014 A classic black prom dress will ... famous dress suppliers, has unveiled its new items of black ... now offered at a big discount, up to 70% off. ... , The new black prom dresses, made with the best ... the needs of all customers, the company provides these beautiful ...
(Date:11/22/2014)... Today, Dylan Queen, a renowned brand in wedding ... the business offers a wide range of special occasion ... allowing them to create multiple looks easily. , According ... collection of chic wedding dresses has been prepared for ... discounted rates now. Dylan Queen can always create what ...
(Date:11/22/2014)... Discount-Dress.com is an important company ... is to increase the company’s online market share by a ... of bridesmaid dresses and announced a bridesmaid dress promotion for ... Dec. 30, 2014. All the dresses from this company are ... In fact, Discount-Dress.com is very good at manufacturing wedding dresses. ...
(Date:11/22/2014)... November 22, 2014 "My friend went ... caused by the machine," said an inventor from Cambria ... to go back a second time because the first ... , She developed the patent-pending MAMO EASY to offer ... The design saves the patient from the pain normally ...
(Date:11/22/2014)... -- The wide variety and complexity of foods served ... with food allergies, an expert warns. "Every person ... food allergies that it can be really difficult to ... director of allergy and clinical immunology at Wake Forest ... "If you know you have food allergies, caution ...
Breaking Medicine News(10 mins):Health News:New Black Prom Dresses from BellasDress.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2Health News:'Tis the Season of Challenges for Those With Food Allergies 2
... young as ten are making themselves vomit in order to ... than girls, according to a study of nearly 16,000 school ... Journal of Clinical Nursing . The findings have ... an early sign that children could develop eating disorders and ...
... 15, 2011) An experimental vaccine developed by researchers ... overactive antigens in highly aggressive brain tumors and improves ... new data that was presented in a poster session ... of Clinical Oncology. Patients with newly diagnosed ...
... of a powerful basic "decision circuit" in breast cancer ... Cancer . The preliminary mathematical model is the ... to scientists at the Lombardi Comprehensive Cancer Center at ... Tech and Fox Chase Cancer Center, to develop a ...
... serious treatment gap is leaving millions of people at ... revealed in ,Osteoporosis: Burden, health care provision and opportunities ... International Osteoporosis Foundation (IOF) in collaboration with the European ... that only a minority of high risk patients are ...
... , THURSDAY, June 16 (HealthDay News) -- The ... is making many people with middle and low incomes ... a lot in the U.S., especially since the 1980s," ... of Virginia, said in news release from the Association ...
... , WEDNESDAY, June 15 (HealthDay News) -- Medical advances have ... survival and plan for the future. But for many of ... In fact, researchers from Penn State found that, on ... in medical care costs than people who have never had ...
Cached Medicine News:Health News:Children as young as 10 vomit to lose weight, with highest rates in boys 2Health News:Latest data from Cedars-Sinai vaccine study supports immune targeting of brain tumors 2Health News:Latest data from Cedars-Sinai vaccine study supports immune targeting of brain tumors 3Health News:Roadmap published for dynamic mapping of estrogen signaling in breast cancer 2Health News:Roadmap published for dynamic mapping of estrogen signaling in breast cancer 3Health News:Treatment gap leaves many older adults at unnecessary risk of fracture 2Health News:Treatment gap leaves many older adults at unnecessary risk of fracture 3Health News:Cancer Survivors Face High Health Costs Over Long Term: Report 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: